Loading…

Combined hydroxypropyl-β-cyclodextrin and poly(alkylcyanoacrylate) nanoparticles intended for oral administration of saquinavir

The aim of this study was to prepare and characterize an hydroxypropyl-β-cyclodextrin–saquinavir inclusion complex with the purpose of incorporating this complex into poly(alkylcyanoacrylate) nanoparticles in order to increase the drug loading. Hydroxypropyl-β-cyclodextrin–saquinavir complex was cha...

Full description

Saved in:
Bibliographic Details
Published in:International journal of pharmaceutics 2001-05, Vol.218 (1), p.113-124
Main Authors: Boudad, H, Legrand, P, Lebas, G, Cheron, M, Duchêne, D, Ponchel, G
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c389t-d20ac4d8b158ec33c968448bb4fce7fdc7ea33746638d01ff75cfb143db7e8943
cites cdi_FETCH-LOGICAL-c389t-d20ac4d8b158ec33c968448bb4fce7fdc7ea33746638d01ff75cfb143db7e8943
container_end_page 124
container_issue 1
container_start_page 113
container_title International journal of pharmaceutics
container_volume 218
creator Boudad, H
Legrand, P
Lebas, G
Cheron, M
Duchêne, D
Ponchel, G
description The aim of this study was to prepare and characterize an hydroxypropyl-β-cyclodextrin–saquinavir inclusion complex with the purpose of incorporating this complex into poly(alkylcyanoacrylate) nanoparticles in order to increase the drug loading. Hydroxypropyl-β-cyclodextrin–saquinavir complex was characterized by thermal (differential scanning calorimetry), crystallographic (X-ray diffractography) and spectroscopic methods (circular dichroism, H 1-NMR). Nanoparticles were prepared by polymerization of alkylcyanoacrylate monomers (isobutyl- and isohexylcyanoacrylate) in a water solution of the complex and further characterized. The apparent solubility of saquinavir was increased 400-fold at pH 7.0 in presence of hydroxypropyl-β-cyclodextrin owing to the formation of a drug–cyclodextrin complex as demonstrated mainly by 1H NMR and confirmed by other techniques. Saquinavir-loaded nanoparticles could be easily prepared in the presence of a drug–cyclodextrin complex. It was found that large amounts of cyclodextrins remained associated with the particles, resulting in a 20-fold increase in saquinavir loading compared to nanoparticles prepared in the absence of cyclodextrins. This study has shown that the loading in saquinavir of poly(alkylcyanoacrylate) nanospheres could be dramatically improved by simultaneously increasing the apparent solubility of the drug in the preparation medium and the amount of cyclodextrin associated with the particles, making these nanospheres a promising system for oral application.
doi_str_mv 10.1016/S0378-5173(01)00622-6
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70808046</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378517301006226</els_id><sourcerecordid>70808046</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-d20ac4d8b158ec33c968448bb4fce7fdc7ea33746638d01ff75cfb143db7e8943</originalsourceid><addsrcrecordid>eNqFkM1u1DAQgC0EotvCI4AiIaH2ELDXSew9VWhVfqRKHICzNRmPhcGxUztbNTeeiQfhmch2V-WI5jAa6Zu_j7EXgr8RXHRvv3CpdN0KJc-5uOC8W6_r7hFbCa1kLRvVPWarB-SEnZbyg-8pIZ-yEyGkVKJtV-zXNg29j2Sr77PN6W4ecxrnUP_5XeOMIVm6m7KPFURbjSnM5xB-zgFniAkwzwEmuqjiUo2QJ4-BSuXjRNEuE13KVcoQKrCDj75MGSafYpVcVeBm5yPc-vyMPXEQCj0_5jP27f3V1-3H-vrzh0_bd9c1Sr2ZarvmgI3VvWg1oZS46XTT6L5vHJJyFhXB8lPTdVJbLpxTLbpeNNL2ivSmkWfs9WHu8uDNjspkBl-QQoBIaVeM4nqJplvA9gBiTqVkcmbMfoA8G8HNXr25V2_2Xg0X5l692fe9PC7Y9QPZf11H1wvw6ghAQQguQ0RfHriNUmq9WajLA0WLjFtP2RT0FJGsz4STscn_55C_LgKlEA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70808046</pqid></control><display><type>article</type><title>Combined hydroxypropyl-β-cyclodextrin and poly(alkylcyanoacrylate) nanoparticles intended for oral administration of saquinavir</title><source>Elsevier</source><creator>Boudad, H ; Legrand, P ; Lebas, G ; Cheron, M ; Duchêne, D ; Ponchel, G</creator><creatorcontrib>Boudad, H ; Legrand, P ; Lebas, G ; Cheron, M ; Duchêne, D ; Ponchel, G</creatorcontrib><description>The aim of this study was to prepare and characterize an hydroxypropyl-β-cyclodextrin–saquinavir inclusion complex with the purpose of incorporating this complex into poly(alkylcyanoacrylate) nanoparticles in order to increase the drug loading. Hydroxypropyl-β-cyclodextrin–saquinavir complex was characterized by thermal (differential scanning calorimetry), crystallographic (X-ray diffractography) and spectroscopic methods (circular dichroism, H 1-NMR). Nanoparticles were prepared by polymerization of alkylcyanoacrylate monomers (isobutyl- and isohexylcyanoacrylate) in a water solution of the complex and further characterized. The apparent solubility of saquinavir was increased 400-fold at pH 7.0 in presence of hydroxypropyl-β-cyclodextrin owing to the formation of a drug–cyclodextrin complex as demonstrated mainly by 1H NMR and confirmed by other techniques. Saquinavir-loaded nanoparticles could be easily prepared in the presence of a drug–cyclodextrin complex. It was found that large amounts of cyclodextrins remained associated with the particles, resulting in a 20-fold increase in saquinavir loading compared to nanoparticles prepared in the absence of cyclodextrins. This study has shown that the loading in saquinavir of poly(alkylcyanoacrylate) nanospheres could be dramatically improved by simultaneously increasing the apparent solubility of the drug in the preparation medium and the amount of cyclodextrin associated with the particles, making these nanospheres a promising system for oral application.</description><identifier>ISSN: 0378-5173</identifier><identifier>EISSN: 1873-3476</identifier><identifier>DOI: 10.1016/S0378-5173(01)00622-6</identifier><identifier>PMID: 11337155</identifier><identifier>CODEN: IJPHDE</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>2-Hydroxypropyl-beta-cyclodextrin ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antiviral agents ; beta-Cyclodextrins ; Biological and medical sciences ; Calorimetry, Differential Scanning ; Chemistry, Pharmaceutical ; Circular Dichroism ; Cyanoacrylates - chemistry ; Cyclodextrins - administration &amp; dosage ; Cyclodextrins - chemistry ; General pharmacology ; HIV Protease Inhibitors - administration &amp; dosage ; HIV Protease Inhibitors - chemistry ; Hydroxypropyl-β-cyclodextrin ; Inclusion complex ; Magnetic Resonance Spectroscopy ; Medical sciences ; Molecular Structure ; Nanoparticles ; Oral administration ; Particle Size ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Polymers - chemistry ; Saquinavir ; Saquinavir - administration &amp; dosage ; Saquinavir - chemistry ; Solubility ; X-Ray Diffraction</subject><ispartof>International journal of pharmaceutics, 2001-05, Vol.218 (1), p.113-124</ispartof><rights>2001 Elsevier Science B.V.</rights><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c389t-d20ac4d8b158ec33c968448bb4fce7fdc7ea33746638d01ff75cfb143db7e8943</citedby><cites>FETCH-LOGICAL-c389t-d20ac4d8b158ec33c968448bb4fce7fdc7ea33746638d01ff75cfb143db7e8943</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=977729$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11337155$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Boudad, H</creatorcontrib><creatorcontrib>Legrand, P</creatorcontrib><creatorcontrib>Lebas, G</creatorcontrib><creatorcontrib>Cheron, M</creatorcontrib><creatorcontrib>Duchêne, D</creatorcontrib><creatorcontrib>Ponchel, G</creatorcontrib><title>Combined hydroxypropyl-β-cyclodextrin and poly(alkylcyanoacrylate) nanoparticles intended for oral administration of saquinavir</title><title>International journal of pharmaceutics</title><addtitle>Int J Pharm</addtitle><description>The aim of this study was to prepare and characterize an hydroxypropyl-β-cyclodextrin–saquinavir inclusion complex with the purpose of incorporating this complex into poly(alkylcyanoacrylate) nanoparticles in order to increase the drug loading. Hydroxypropyl-β-cyclodextrin–saquinavir complex was characterized by thermal (differential scanning calorimetry), crystallographic (X-ray diffractography) and spectroscopic methods (circular dichroism, H 1-NMR). Nanoparticles were prepared by polymerization of alkylcyanoacrylate monomers (isobutyl- and isohexylcyanoacrylate) in a water solution of the complex and further characterized. The apparent solubility of saquinavir was increased 400-fold at pH 7.0 in presence of hydroxypropyl-β-cyclodextrin owing to the formation of a drug–cyclodextrin complex as demonstrated mainly by 1H NMR and confirmed by other techniques. Saquinavir-loaded nanoparticles could be easily prepared in the presence of a drug–cyclodextrin complex. It was found that large amounts of cyclodextrins remained associated with the particles, resulting in a 20-fold increase in saquinavir loading compared to nanoparticles prepared in the absence of cyclodextrins. This study has shown that the loading in saquinavir of poly(alkylcyanoacrylate) nanospheres could be dramatically improved by simultaneously increasing the apparent solubility of the drug in the preparation medium and the amount of cyclodextrin associated with the particles, making these nanospheres a promising system for oral application.</description><subject>2-Hydroxypropyl-beta-cyclodextrin</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antiviral agents</subject><subject>beta-Cyclodextrins</subject><subject>Biological and medical sciences</subject><subject>Calorimetry, Differential Scanning</subject><subject>Chemistry, Pharmaceutical</subject><subject>Circular Dichroism</subject><subject>Cyanoacrylates - chemistry</subject><subject>Cyclodextrins - administration &amp; dosage</subject><subject>Cyclodextrins - chemistry</subject><subject>General pharmacology</subject><subject>HIV Protease Inhibitors - administration &amp; dosage</subject><subject>HIV Protease Inhibitors - chemistry</subject><subject>Hydroxypropyl-β-cyclodextrin</subject><subject>Inclusion complex</subject><subject>Magnetic Resonance Spectroscopy</subject><subject>Medical sciences</subject><subject>Molecular Structure</subject><subject>Nanoparticles</subject><subject>Oral administration</subject><subject>Particle Size</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Polymers - chemistry</subject><subject>Saquinavir</subject><subject>Saquinavir - administration &amp; dosage</subject><subject>Saquinavir - chemistry</subject><subject>Solubility</subject><subject>X-Ray Diffraction</subject><issn>0378-5173</issn><issn>1873-3476</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNqFkM1u1DAQgC0EotvCI4AiIaH2ELDXSew9VWhVfqRKHICzNRmPhcGxUztbNTeeiQfhmch2V-WI5jAa6Zu_j7EXgr8RXHRvv3CpdN0KJc-5uOC8W6_r7hFbCa1kLRvVPWarB-SEnZbyg-8pIZ-yEyGkVKJtV-zXNg29j2Sr77PN6W4ecxrnUP_5XeOMIVm6m7KPFURbjSnM5xB-zgFniAkwzwEmuqjiUo2QJ4-BSuXjRNEuE13KVcoQKrCDj75MGSafYpVcVeBm5yPc-vyMPXEQCj0_5jP27f3V1-3H-vrzh0_bd9c1Sr2ZarvmgI3VvWg1oZS46XTT6L5vHJJyFhXB8lPTdVJbLpxTLbpeNNL2ivSmkWfs9WHu8uDNjspkBl-QQoBIaVeM4nqJplvA9gBiTqVkcmbMfoA8G8HNXr25V2_2Xg0X5l692fe9PC7Y9QPZf11H1wvw6ghAQQguQ0RfHriNUmq9WajLA0WLjFtP2RT0FJGsz4STscn_55C_LgKlEA</recordid><startdate>20010507</startdate><enddate>20010507</enddate><creator>Boudad, H</creator><creator>Legrand, P</creator><creator>Lebas, G</creator><creator>Cheron, M</creator><creator>Duchêne, D</creator><creator>Ponchel, G</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20010507</creationdate><title>Combined hydroxypropyl-β-cyclodextrin and poly(alkylcyanoacrylate) nanoparticles intended for oral administration of saquinavir</title><author>Boudad, H ; Legrand, P ; Lebas, G ; Cheron, M ; Duchêne, D ; Ponchel, G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-d20ac4d8b158ec33c968448bb4fce7fdc7ea33746638d01ff75cfb143db7e8943</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>2-Hydroxypropyl-beta-cyclodextrin</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antiviral agents</topic><topic>beta-Cyclodextrins</topic><topic>Biological and medical sciences</topic><topic>Calorimetry, Differential Scanning</topic><topic>Chemistry, Pharmaceutical</topic><topic>Circular Dichroism</topic><topic>Cyanoacrylates - chemistry</topic><topic>Cyclodextrins - administration &amp; dosage</topic><topic>Cyclodextrins - chemistry</topic><topic>General pharmacology</topic><topic>HIV Protease Inhibitors - administration &amp; dosage</topic><topic>HIV Protease Inhibitors - chemistry</topic><topic>Hydroxypropyl-β-cyclodextrin</topic><topic>Inclusion complex</topic><topic>Magnetic Resonance Spectroscopy</topic><topic>Medical sciences</topic><topic>Molecular Structure</topic><topic>Nanoparticles</topic><topic>Oral administration</topic><topic>Particle Size</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Polymers - chemistry</topic><topic>Saquinavir</topic><topic>Saquinavir - administration &amp; dosage</topic><topic>Saquinavir - chemistry</topic><topic>Solubility</topic><topic>X-Ray Diffraction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Boudad, H</creatorcontrib><creatorcontrib>Legrand, P</creatorcontrib><creatorcontrib>Lebas, G</creatorcontrib><creatorcontrib>Cheron, M</creatorcontrib><creatorcontrib>Duchêne, D</creatorcontrib><creatorcontrib>Ponchel, G</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of pharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boudad, H</au><au>Legrand, P</au><au>Lebas, G</au><au>Cheron, M</au><au>Duchêne, D</au><au>Ponchel, G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Combined hydroxypropyl-β-cyclodextrin and poly(alkylcyanoacrylate) nanoparticles intended for oral administration of saquinavir</atitle><jtitle>International journal of pharmaceutics</jtitle><addtitle>Int J Pharm</addtitle><date>2001-05-07</date><risdate>2001</risdate><volume>218</volume><issue>1</issue><spage>113</spage><epage>124</epage><pages>113-124</pages><issn>0378-5173</issn><eissn>1873-3476</eissn><coden>IJPHDE</coden><abstract>The aim of this study was to prepare and characterize an hydroxypropyl-β-cyclodextrin–saquinavir inclusion complex with the purpose of incorporating this complex into poly(alkylcyanoacrylate) nanoparticles in order to increase the drug loading. Hydroxypropyl-β-cyclodextrin–saquinavir complex was characterized by thermal (differential scanning calorimetry), crystallographic (X-ray diffractography) and spectroscopic methods (circular dichroism, H 1-NMR). Nanoparticles were prepared by polymerization of alkylcyanoacrylate monomers (isobutyl- and isohexylcyanoacrylate) in a water solution of the complex and further characterized. The apparent solubility of saquinavir was increased 400-fold at pH 7.0 in presence of hydroxypropyl-β-cyclodextrin owing to the formation of a drug–cyclodextrin complex as demonstrated mainly by 1H NMR and confirmed by other techniques. Saquinavir-loaded nanoparticles could be easily prepared in the presence of a drug–cyclodextrin complex. It was found that large amounts of cyclodextrins remained associated with the particles, resulting in a 20-fold increase in saquinavir loading compared to nanoparticles prepared in the absence of cyclodextrins. This study has shown that the loading in saquinavir of poly(alkylcyanoacrylate) nanospheres could be dramatically improved by simultaneously increasing the apparent solubility of the drug in the preparation medium and the amount of cyclodextrin associated with the particles, making these nanospheres a promising system for oral application.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>11337155</pmid><doi>10.1016/S0378-5173(01)00622-6</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0378-5173
ispartof International journal of pharmaceutics, 2001-05, Vol.218 (1), p.113-124
issn 0378-5173
1873-3476
language eng
recordid cdi_proquest_miscellaneous_70808046
source Elsevier
subjects 2-Hydroxypropyl-beta-cyclodextrin
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antiviral agents
beta-Cyclodextrins
Biological and medical sciences
Calorimetry, Differential Scanning
Chemistry, Pharmaceutical
Circular Dichroism
Cyanoacrylates - chemistry
Cyclodextrins - administration & dosage
Cyclodextrins - chemistry
General pharmacology
HIV Protease Inhibitors - administration & dosage
HIV Protease Inhibitors - chemistry
Hydroxypropyl-β-cyclodextrin
Inclusion complex
Magnetic Resonance Spectroscopy
Medical sciences
Molecular Structure
Nanoparticles
Oral administration
Particle Size
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
Polymers - chemistry
Saquinavir
Saquinavir - administration & dosage
Saquinavir - chemistry
Solubility
X-Ray Diffraction
title Combined hydroxypropyl-β-cyclodextrin and poly(alkylcyanoacrylate) nanoparticles intended for oral administration of saquinavir
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T05%3A30%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Combined%20hydroxypropyl-%CE%B2-cyclodextrin%20and%20poly(alkylcyanoacrylate)%20nanoparticles%20intended%20for%20oral%20administration%20of%20saquinavir&rft.jtitle=International%20journal%20of%20pharmaceutics&rft.au=Boudad,%20H&rft.date=2001-05-07&rft.volume=218&rft.issue=1&rft.spage=113&rft.epage=124&rft.pages=113-124&rft.issn=0378-5173&rft.eissn=1873-3476&rft.coden=IJPHDE&rft_id=info:doi/10.1016/S0378-5173(01)00622-6&rft_dat=%3Cproquest_cross%3E70808046%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c389t-d20ac4d8b158ec33c968448bb4fce7fdc7ea33746638d01ff75cfb143db7e8943%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=70808046&rft_id=info:pmid/11337155&rfr_iscdi=true